Welsis (WLSS) Return on Sales (2022 - 2024)

Welsis (WLSS) recorded quarterly Return on Sales of 0.32% in Q3 2024, down 1648.3% quarter-over-quarter from 0.02% in Q2 2024, and down 32.0% on a YoY basis from 0.47% in Q4 2023.

Welsis (WLSS) Return on Sales (2022 - 2024) Analysis & Trends

Welsis' Return on Sales history runs 3 years deep, the most recent figure standing at 0.32% for Q3 2024.

  • In Q3 2024, Return on Sales fell 32.0% year-over-year to 0.32%; the TTM figure through Sep 2024 stood at 0.32% (down 31.0% YoY), while the FY2024 annual figure was 0.32%, down 31.0% from the prior year.
  • Return on Sales was 0.32% for Q3 2024 at Welsis, down from 0.02% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.0% in Q3 2023 to a low of 0.32% in Q3 2024.
  • Historically, Return on Sales has averaged 0.08% across 3 years, with a median of 0.02% in 2022.
  • Biggest YoY gain for Return on Sales was 16 bps in 2024; the steepest drop was 32 bps in 2024.
  • A 3-year view of Return on Sales shows it stood at 0.03% in 2022, then plunged by 152 bps to 0.07% in 2023, then tumbled by 385 bps to 0.32% in 2024.
  • The last three Return on Sales figures came in at 0.32% (Q3 2024), 0.02% (Q2 2024), and 0.01% (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 0.00%
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 0.00%
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 0.00%
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 0.00%
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 0.00%
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 0.00%
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 0.00%
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 0.00%
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 0.00%
10 Welsis - - - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -0.32%
Jun 30, 2024 -0.02%
Mar 31, 2024 -0.01%
Dec 31, 2023 -0.07%
Sep 30, 2023 0.00%
Jun 30, 2023 -0.01%
Mar 31, 2023 -0.18%
Dec 31, 2022 -0.03%